Biotechnology Support

Bioprocessing and CMC development for biologics

Axys-Network supports biomanufacturers in developing and industrialising their processes, with in-depth CMC expertise from a network of senior consultants specialised in biological products. We strengthen your project teams across the whole biopharmaceutical value chain, from preclinical research to commercial manufacturing.

Therapeutic proteins Monoclonal antibodies (mAbs) Viral vectors (AAV, lentivirus) Gene therapies and ATMPs Immunotherapies

Who is it for?

First clinical trial Biotech start-up You are initiating your first Phase I clinical trial and need to build your CMC dossier.
Late-stage development Biopharma Your proof of concept is validated and you are ready to invest in Phase II and III and a potential commercial launch.
New biological entities Pharmaceutical company Experienced with traditional products, you are now developing new biological entities.

Upstream – cell culture and fermentation

From cell line development to cell culture and fermentation, our experts help you:

  • improve yields and cell productivity;
  • control variability with QbD (Quality by Design) approaches;
  • scale up successfully from lab to plant;
  • reduce contamination risks and make your process more robust;
  • gain flexibility with single-use technologies and PAT (Process Analytical Technology).
See also: monoclonal antibodies, ADCs and downstream processes, Engineering page →

Downstream – purification and viral safety

Downstream processing accounts for 60 to 80% of production costs. We help you strike the right balance between purity and yield while maintaining viral safety and regulatory compliance:

  • purification strategies;
  • viral clearance and inactivation;
  • scale-down and scale-up;
  • production cost reduction.

Fill & Finish – aseptic filling

Sterility assurance in contexts specific to biologics: fragile molecules, low fill volumes and small numbers of containers. Our experts draw on Axys-Network's aseptic processing experience: Media Fill, isolators, Annex 1 and contamination control strategy.

See our manufacturing and aseptic processing expertise →

CMC development plan

Consultants experienced in biological products and advanced therapies build your CMC development plan with you, from cell banking to Phase III material and commercial launch, to maximise your chances of success with the FDA and EMA.

  • assessment of your process with your subject-matter experts;
  • assessment, with your analytical development team, of the robustness and scalability of your QC methods;
  • an improvement plan to secure the registration of your CMC dossier.

ICH-compliant pharmaceutical development

Our consultants are experienced with ICH guidelines Q1 to Q14, including the specificities of biological products and how expectations progress from Phase I to BLA.

Some points are difficult without experience, such as the appropriate level of analytical method validation and process validation during clinical development. We make sure your GMP compliance moves ahead with your clinical development phases.

Coaching your teams – IMPD and BLA

Technical expertise is essential, but it is not the complete set of cards needed to build a CMC dossier and succeed with an IMPD or BLA submission. Our consultants coach your subject-matter experts to build robust files and respond to questions from health authorities.

CDMO selection and management

We help you select your future CDMOs, negotiate contracts and, if needed, manage day-to-day interactions.

See our CMO / CDMO selection approach →

Deviations and batch compliance

Deviations will occur during your manufacturing operations. Our consultants help you implement corrective and preventive actions (CAPA).

With their QP and inspection-readiness experience, they assess the compliance of your first batches against biological specificities, taking into account the value of the product, especially for ATMPs.

Interactions with authorities

Communicating with the FDA and other agencies can be intimidating, whether for routine exchanges of information or briefing packages for meetings with authorities. Our experts have the experience to help you.

Why Axys-Network?

A former senior CMC director oversees your programme; hands-on experts deliver it with you on the ground.

Our experts work at the level you need, from mentoring all the way to authoring procedures and training your teams. Based in Europe, they work in your time zone and your language. An agile and rigorous partner, Axys-Network helps you meet technical challenges, ensure regulatory compliance and accelerate time to market.

Your expert

Meet the team →
Lead expertPatrick MahieuxBiotechnology and CMC development

A process to industrialise or a CMC dossier to secure?

Talk to our lead biotechnology expert: we will propose the right consultant for your project.

Contact us Interim management